Fiche du document
- doi: 10.1016/j.nmni.2021.100899
- issn: 2052-2975
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.nmni.2021.100899
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34007453
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2052-2975
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B2C6AA99CFBC0
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
RatCiter ce document
G. Caruana et al., « The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. », Serveur académique Lausannois, ID : 10.1016/j.nmni.2021.100899
Métriques
Partage / Export
Résumé
Several reports showed SARS-CoV-2 rapid antigen tests (RATs) performances among COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions, but few data are present for asymptomatic patients. We investigated the role of RATs in an emergency department, as a novel screening tool before admission for COVID-19 asymptomatic patients. A total of 116 patients were screened on admission in a 250-bed community hospital in Morges, Switzerland. RAT detected 2/7 RT-PCR-positive patients and delivered two false-positive results. These data suggest the non-fiability of RATs screening in this clinical scenario.